Sequential Therapy with IMID's in Relapsed-Refractory Multiple Myeloma Patients

被引：0

作者：

Guglielmelli, Tommasina ^{[1
,2
]}

Bringhen, Sara ^{[1
,3
]}

Berruti, Alfredo ^{[1
,2
]}

Gay, Francesca ^{[1
,3
]}

Cavallo, Federica ^{[1
,3
]}

Montefusco, Vittorio ^{[4
]}

Genuardi, Mariella ^{[1
,3
]}

Piro, Eugenio ^{[5
]}

Petrucci, Maria Teresa ^{[6
]}

Caravita, Tommaso ^{[7
]}

Offidani, Massimo

Corradini, Paolo ^{[4
,8
]}

Boccadoro, Mario ^{[1
,3
]}

Saglio, Giuseppe ^{[1
,2
]}

Palumbo, Antonio ^{[1
,3
]}

机构：

[1] Univ Turin, Orbassano, Italy

[2] San Luigi Hosp, Orbassano, Italy

[3] San Giovanni Battista Hosp, Turin, Italy

[4] Ist Nazl Tumori, I-20133 Milan, Italy

[5] Div Hematol, Catanzaro, Italy

[6] Univ Roma La Sapienza, Rome, Italy

[7] Univ Roma Tor Vergata, Rome, Italy

[8] Polo Osped Univ, Osped Riuniti Ancona, Ancona, Italy

来源：

BLOOD | 2009年 / 114卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1128 / 1128

页数：1

共 50 条

[1] Therapy of relapsed and relapsed-refractory Multiple Myeloma
Driessen, C.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 8 - 8
[2] Monoclonal Antibodies in Relapsed-Refractory Multiple Myeloma
Sorgiovanni, Ilaria
Del Giudice, Maria Livia
Galimberti, Sara
Buda, Gabriele
PHARMACEUTICALS, 2025, 18 (02)
[3] Bortezomib in patients with relapsed-refractory multiple myeloma (MM). Clinical observations.
Kyrtsonis, MC
Sachanas, S
Vassilakopoulos, TP
Kafassi, N
Tzenou, T
Papadogiannis, A
Kalpadakis, C
Antoniadis, AG
Dimopoulou, MN
Angelopoulou, MK
Siakantaris, MP
Dimitriadou, EM
Kokoris, SI
Plata, E
Tsaftaridis, P
Panayiotidis, P
Pangalis, GA
BLOOD, 2005, 106 (11) : 382B - 382B
[4] Thalidomide plus melphalan in relapsed-refractory multiple myeloma.
Offidani, M
Mele, A
Marconi, M
Corvatta, L
Candela, M
Pieroni, S
Malerba, L
Rupoli, S
Olivieri, A
Leoni, P
BLOOD, 2001, 98 (11) : 311B - 311B
[5] Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments
Cancanelli, Luca
Rivano, Melania
Di Spazio, Lorenzo
Chiumente, Marco
Mengato, Daniele
Messori, Andrea
HEMATOLOGY REPORTS, 2023, 15 (01) : 57 - 65
[6] Prompt and Profound Responses with Talquetamab in Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma - Another Bridging Therapy
Shaikh, Hira
Lochner, Jonathan
Davis, James
Snyder, Jordan
Friend, Reed
Patrus, Gina
DiLeo, Rachel
Mushtaq, Muhammad Umair
Green, Kimberly
Mewawalla, Prerna
Struble, Emily
Kussatz, Shannon
Ahmed, Nausheen
Abdallah, Al-Ola
Atrash, Shebli
Hashmi, Hamza
Paul, Barry
Strouse, Christopher
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S86 - S87
[7] Therapy of relapsed and relapsed refractory multiple myeloma
Driessen, C.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 113 - 113
[8] Longterm trrapyand efficacy of low-dosethalidomide in relapsed-refractory multiple myeloma patients
Canepa, L.
Aquino, S.
Ballerini, F.
Balocco, M.
Miglino, M.
Gobbi, M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 432 - 433
[9] LENALIDOMIDE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
Okada, K.
Okamoto, Y.
Tsukamoto, T.
Sugiura, H.
Matsui, H.
Ueda, T.
Jo, T.
Onishi, T.
Kunitomi, A.
Ueda, Y.
ANNALS OF ONCOLOGY, 2013, 24
[10] Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data
Offidani, Massimo
Corvatta, Laura
Caraffa, Patrizia
Leoni, Pietro
Pautasso, Chiara
Larocca, Alessandra
Palumbo, Antonio
EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (05) : 499 - 510

← 1 2 3 4 5 →